Primary Job Title Chief Scientific Advisor Primary Organization 
Naurex
Gender Male
LinkedIn View on LinkedIn
Dr. Leander is currently an advisor to a number of biopharmaceutical companies. Previously, he worked for more than 20 years at Eli Lilly & Co., where he was a Lilly Research Fellow and chair of the neuroscience discovery group that produced Prozac®, Zyprexa®, Strattera® and Cymbalta®, as well as many other drug development programs, including
Lilly’s NMDA receptor modulator program. Dr. Leander has authored more than 200 scientific publications. He received a BA from Pacific Lutheran University, an MA from Western Washington University, a PhD from the University of Florida and an MBA from Indiana University.
